Inventor · disambiguated record
Paul Matthew Blaney
Also filed as: BLANEY PAUL · BLANEY PAUL M · BLANEY PAUL MATTHEW
8 granted patents·8 pending applications·192 citations·filing 2005–2023
87Inventor score
Top patents by PatentIndex Score
16 records- 0196US7928237B2Fused ring azadecalin glucocorticoid receptor modulatorsCORCEPT THERAPEUTICS INC·Filed 2005·Granted Apr 19, 2011·87 cites·10 claims
- 0294US7678813B2Azadecalin Glucocorticoid receptor modulatorsCORCEPT THERAPEUTICS INC·Filed 2005·Granted Mar 16, 2010·42 cites·21 claims
- 0392US8557839B2Fused ring azadecalin glucocorticoid receptor modulatorsCLARK ROBIN D·Filed 2012·Granted Oct 15, 2013·29 cites·9 claims
- 0490US8324203B2Azadecalin glucocorticoid receptor modulatorsCLARK ROBIN D·Filed 2010·Granted Dec 4, 2012·22 cites·5 claims
- 0588US9957235B2Benzimidazol-2-amines as mIDH1 inhibitorsBayer Pharma AG·Filed 2015·Granted May 1, 2018·8 cites·34 claims
- 0679US10137110B21-cyclohexyl-2-phenylaminobenzimidazoles as mIDH1 inhibitors for the treatment of tumorsBayer Pharma AG·Filed 2015·Granted Nov 27, 2018·4 cites·29 claims
- 0758US2025136577A1Heterocyclic derivatives as malt1 inhibitorsC4X DISCOVERY LTD·Filed 2023·Application pending·0 cites
- 0858US2014179671A1Fused ring azadecalin glucocorticoid receptor modulatorsCORCEPT THERAPEUTICS INC·Filed 2013·Application pending·0 cites
- 0953US2011166110A1Fused Ring Azadecalin Glucocorticoid Receptor ModulatorsCORCEPT THERAPEUTICS INC·Filed 2011·Application pending·0 cites
- 1051US10442772B2Benzimidazol-2-amines as mIDH1 inhibitorsBayer Pharma AG·Filed 2018·Granted Oct 15, 2019·0 cites·21 claims
- 1143US11400081B2CompoundsUNIV SHEFFIELD·Filed 2018·Granted Aug 2, 2022·0 cites·21 claims
- 1239US2013274258A1Carbazole and carboline derivatives, and preparation and therapeutic applications thereofDEMOTZ STEPHANE·Filed 2011·Application pending·0 cites
- 1336US2010137300A1Indolizine Acetic Acid Derivatives as CRTH2 AntagonistsHYND GEORGE·Filed 2007·Application pending·0 cites
- 1436US2009163534A1Indolizine DerivativesHYND GEORGE·Filed 2006·Application pending·0 cites
- 1536US2010010034A1Crth2 antagonistsHYND GEORGE·Filed 2006·Application pending·0 cites
- 1635US2008306109A1Indolizine Derivatives as Ligands of the Crth2 ReceptorHYND GEORGE·Filed 2006·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Paul Matthew Blaney files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →